Press Release: Ibotta, Inc. Investor News: If You Have Suffered Losses in Ibotta, Inc. (NYSE: IBTA) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, March 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA) resulting from allegations that Ibotta may have issued materially misleading business information to the investing public.
MARKHAM, Ontario, July 07, 2025 (GLOBE NEWSWIRE) -- Almost one third (32 per cent) of Canadian respondents to a survey that say they are active on social media post about their plans before or while traveling, a figure that rises to 51 per cent among those aged 18 to 34. Posting that beach vacation selfie…
Société Européenne au capital de € 361 015 032 - 582 110 987 R.C.S Paris30 avenue Montaigne - 75008 Paris INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Las Vegas, NV, July 06, 2025 (GLOBE NEWSWIRE) -- In a landmark achievement that solidifies Area 52's position as the Delta 8 market leader, The Oregon Observer's extensive 2025 cannabis edibles review has awarded the top Delta 8 gummy rankings to Area 52's innovative product line. This unprecedented sweep demonstrates the brand's unwavering commitment to…
SHELTON, Conn., July 06, 2025 (GLOBE NEWSWIRE) -- Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EGT Synbio, headquartered in Shanghai, China, has successfully completed two human clinical trials evaluating the effects of oral L-ergothioneine (Dr.Ergo®) on skin health. Abinopharm, Inc. is the…
SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with the potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD)…
Thu, 12 Jun 2025 10:00:00 GMT This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. ... IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN IBOTTA, INC.
Mon, 09 Jun 2025 01:44:00 GMT --Robbins Geller Rudman& Dowd LLP announces that purchasers or acquirers of Ibotta, Inc. publicly traded securities pursuant and/or traceable to Ibotta’ s registration statement and related ...
Sun, 08 Jun 2025 06:13:00 GMT New York, New York--(Newsfile Corp. - June 8, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ibotta, Inc. ("Ibotta" or the "Company") ...
Wed, 28 May 2025 10:00:00 GMT LOS ANGELES, May 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Ibotta, Inc. ("Ibotta" or the "Company") (NYSE: IBTA) have opportunity to ...
